50 results
Page 2 of 3
8-K
EX-99.1
t35w10dm2nhf4xvgu67o
24 Mar 22
Yumanity Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Developments
4:21pm
8-K
313m 9oc67zt24vpbj
17 Feb 22
Yumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces Restructuring
8:37am
8-K
EX-99.1
xwk3vd6cggvh
17 Feb 22
Yumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces Restructuring
8:37am
8-K/A
EX-99.1
kovsbrdie bsvh2t
8 Apr 21
Financial Statements and Exhibits
8:42am
8-K/A
EX-99.6
ewi d028ri5
3 Feb 21
Other Events
4:59pm
8-K
EX-99.2
85jggs2iz
4 Dec 20
Other Events
5:17pm
425
EX-99.2
tl59ujh
4 Dec 20
Business combination disclosure
5:16pm
424B3
43s8s emlwvk
12 Nov 20
Prospectus supplement
6:08am
S-4/A
0y6b06gg
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm
CORRESP
cdhg81y8p93if4
28 Oct 20
Correspondence with SEC
12:00am
S-4
4tb97ncudbea p3rryhf
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
8-K
o9m6q1xb8uofoalk
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
8-K
EX-99.1
ry5df y4ee4v0k
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
8-K
EX-99.3
r7qa6s2h0n4zfr
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
425
EX-99.1
s85vjcegk9hv5 k3zpfd
24 Aug 20
Business combination disclosure
5:28pm